Gerson Lehrman Group - Intelligently Connecting Institutions and Expertise.

Mr. Michael Sosnowik RPh, PD

President, MSS Consultants, LLC

What is a GLG Leader?|GLG Leaders are a separate tier of Council Members with a Council Rank in the top 5%. These GLG Member Program participants are eligible for ongoing, in-depth consultative relationships with GLG clients.

Member of the Healthcare Council

Council Member Biography

Michael Sosnowik, PD, Pharmacist and former C-Level executive in pharma distribution, is the President of MSS Consultants, an independent consulting firm to pharmaceutical manufacturers, distributors as well as managed care providers, in New York, since September 2007. Previously, Mr. Sosnowik was the Chief Executive Officer of LAB123. He has held upper level management positions in retail pharmacy, institutional and managed care pharmacies, and the wholesale trade. Mr. Sosnowick's experience includes membership on formulary, pharmacy and therapeutics committees as well as day to day operational responsibility. He has also served as the President of QK Healthcare. (This is me - Update Profile)


Employment History

2007 - 2007
President, Giant
2007 - Unspecified
President, MSS Consultants, LLC
2006 - 2007
President and Chief Executive Officer, LAB 123, Inc.
1995 - 2005
President, QK HEALTHCARE, INC

GLG NewsSM Analyses by Michael Sosnowik(?)

Opinions and analyses expressed in GLG News are solely those of the author. See the Terms of Use for details.

Pill splitting

June 19, 2007

'Pill Splitting' Cuts Drug Costs for Patients, Health Plans | www.forbes.com

The article glossed over issues such as pharmacist/pharmacy involvement, tablet scoring, and narrow thereapeutic range drugs, all of which can can profound impact into this practice.

DexCom

June 7, 2007

DexCom Receives FDA Approval For 7-Day STS Continuous Glucose Monitoring System | www.medicaldesignonline.com

cost ease of use

Lybrel

June 7, 2007

FDA Clears Wyeth Contraceptive Pill | online.wsj.com

-side effect profile -3rd party reimbursement -patient cost

wyeth

June 7, 2007

FDA Clears Wyeth Contraceptive Pill | online.wsj.com

The side effect profile and impact will be the key indicator whether this product is as successful as it can be.

Request a consultation with Michael Sosnowik

Leading institutions connect with Michael Sosnowik through GLG

GLG Study Groups with Michael Sosnowik(?)

Study Group Name No. Members
Generic Drug Economic Experts 766
Economic Experts on Managed Care 714
Former C-Level Executives in the Healthcare Council in Member Programs 289
Generic Pharmaceuticals Regulation Experts: Healthcare Consultants 45

GLG Live Meetings with Michael Sosnowik(?)

Michael Sosnowik has not participated in any GLG Live Meetings.

View all GLG Live Meetings in Healthcare